Gabriella Badoni

Gabriella Badoni

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2019 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
GTGiuseppe Tarantini
Giuseppe Tarantini
LFLuca Nai Fovino
Luca Nai Fovino
PDPaola D'ERrigo
Paola D'ERrigo
SRStefano Rosato
Stefano Rosato
MBMarco Barbanti
Marco Barbanti
FGfor the OBSERVANT Research Group
for the OBSERVANT Research Group

1 March 2008 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
PDF file
PDPaola D’Errigo
Paola D’Errigo
FSFulvia Seccareccia
Fulvia Seccareccia
SRStefano Rosato
Stefano Rosato
VMValerio Manno
Valerio Manno
GBGabriella Badoni
Gabriella Badoni
CPCarlo A. Perucci
Carlo A. Perucci
Objectives: To compare the risk-adjustment model empirically derived from the ‘Italian CABG Outcome Project’ with that of the additive and logistic EuroSCORE in terms of accuracy, predictive power and ability to rank hospital performances. Methods: The Italian CABG model, the logistic and additive EuroSCORE were applied to the Italian CABG population; the observed deaths/expected deaths (O/E) ratios, as obtained by the three models, were computed for each Italian cardiac surgery centre and for six classes of risk-stratified patients. The performance of the three models in predicting the 30-day mortality was formally assessed for calibration (Hosmer–Lemeshow test) and discrimination (ROC area). According to the three models, risk-adjusted mortality rates (RAMR = O/E × Italian CABG population mortality rate) were estimated for each centre; possible differences were detected in the identification of hospitals with mortality rates higher and lower than average. Results: The Italian CABG model uses fewer variables than the EuroSCORE system (14 vs 17) and exhibits the best performance in terms of discrimination and calibration. Contrary to the other tested models, the logistic EuroSCORE shows a significant Hosmer–Lemeshow test ( , p < 0.0001), indicating unsatisfactory calibration, and a clear predicted death overestimation in each of the considered risk classes (O/E = 0.4). When a proper recalibration procedure is applied, the logistic EuroSCORE performance parameters achieve acceptable levels. The Italian CABG model identified seven centres as having higher than average mortality, while the EuroSCORE identified the same seven centres plus one other. The Italian CABG model identified eight centres with lower than average mortality, five of which were identified by the additive EuroSCORE and four of which were identified by the logistic EuroSCORE. The additive EuroSCORE identified four more and the logistic EuroSCORE three more low mortality centres. Conclusions: Although this analysis reveals a satisfactory concordance between results from the three models, a detailed comparison shows that the Italian CABG model uses fewer variables and performs better than the others. Nevertheless, when properly recalibrated, the EuroSCORE model can be exported to the Italian population and used to rank hospital performance and evaluate preoperative risk of patients undergoing open-heart surgery.

3 October 2022 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
MMMauro Massussi
Mauro Massussi
MAMarianna Adamo
Marianna Adamo
SRStefano Rosato
Stefano Rosato
FSFulvia Seccareccia
Fulvia Seccareccia
MBMarco Barbanti
Marco Barbanti
PDPaola D'ERrigo
Paola D'ERrigo

28 February 2013 in Journal of Cardiac Surgery
Verified
Journal Article
Closed access
PDPaola D’Errigo
Paola D’Errigo
Fausto BiancariFausto Biancari
Fausto Biancari
AMAlice Maraschini
Alice Maraschini
SRStefano Rosato
Stefano Rosato
GBGabriella Badoni
Gabriella Badoni
FSFulvia Seccareccia
Fulvia Seccareccia
Young patients requiring myocardial revascularization are considered at low operative risk, but data on their outcome are scarce. This study was undertaken to evaluate the prevalence and 30-day mortality of patients aged <50 years after isolated coronary artery bypass surgery (CABG). This is a multicenter study including 2207 patients aged <50 years undergoing isolated CABG at 68 Italian hospitals. The proportion of patients aged <50 years in this series was 5.3% and varied significantly from 0% to 9.9% in different institutions (p < 0.0001). The 30-day mortality rate was 0.9%. One-to-one propensity score matching of patients aged <50 years versus older patients resulted in 2013 pairs whose 30-day mortality was 0.9% and 2.2%, respectively (p = 0.001). Logistic regression showed that left ventricular ejection fraction <30% (OR 5.5, 95% CI 1.6-18.6), peripheral vascular disease (OR 3.6, 95% CI 1.1-12.0), pulmonary hypertension (OR 18.1, 95% CI 1.8-187.0), critical preoperative state (OR 4.7, 95% CI 1.5-14.3), and emergency operation (OR 3.8, 95% CI 1.1-12.9) were independent predictors of 30-day mortality. Meta-analysis of five studies reporting on patients aged <50 years who underwent isolated CABG showed that operative mortality in these patients was 0.9% (95% CI, 0.8-1.1%, I(2) 0%, 135/14,316 patients). The proportion of patients aged <50 years undergoing CABG is low and varies significantly among institutions. The results of this study and a meta-analysis of the literature data showed that CABG can be carried out in young patients with an extremely low risk of operative mortality.

20 August 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SRStefano Rosato
Stefano Rosato
Fausto BiancariFausto Biancari
Fausto Biancari
PDPaola D’Errigo
Paola D’Errigo
MBMarco Barbanti
Marco Barbanti
GTGiuseppe Tarantini
Giuseppe Tarantini
OGon behalf of the OBSERVANT II Research Group
on behalf of the OBSERVANT II Research Group
The superiority of transcatheter (TAVR) over surgical aortic valve replacement (SAVR) for severe aortic stenosis (AS) has not been fully demonstrated in a real-world setting. This prospective study included 5706 AS patients who underwent SAVR from 2010 to 2012 and 2989 AS patients who underwent TAVR from 2017 to 2018 from the prospective multicenter observational studies OBSERVANT I and II. Early adverse events as well as all-cause mortality, major adverse cardiac and cerebrovascular events (MACCEs), and hospital readmission due to heart failure at 1-year were investigated. Among 1008 propensity score matched pairs, TAVR was associated with significantly lower 30-day mortality (1.8 vs. 3.5%, p = 0.020), stroke (0.8 vs. 2.3%, p = 0.005), and acute kidney injury (0.6 vs. 8.2%, p < 0.001) compared to SAVR. Moderate-to-severe paravalvular regurgitation (5.9 vs. 2.0%, p < 0.001) and permanent pacemaker implantation (13.8 vs. 3.3%, p < 0.001) were more frequent after TAVR. At 1-year, TAVR was associated with lower risk of all-cause mortality (7.9 vs. 11.5%, p = 0.006), MACCE (12.0 vs. 15.8%, p = 0.011), readmission due to heart failure (10.8 vs. 15.9%, p < 0.001), and stroke (3.2 vs. 5.1%, p = 0.033) compared to SAVR. TAVR reduced 1-year mortality in the subgroups of patients aged 80 years or older (HR 0.49, 95% CI 0.33–0.71), in females (HR 0.57, 0.38–0.85), and among patients with EuroSCORE II ≥ 4.0% (HR 0.48, 95% CI 0.32–0.71). In a real-world setting, TAVR using new-generation devices was associated with lower rates of adverse events up to 1-year follow-up compared to SAVR.

17 May 2021 in Interactive CardioVascular and Thoracic Surgery
Verified
Journal Article
Open access
PDF file
FBFabio Barili
Fabio Barili
PDPaola D’eRrigo
Paola D’eRrigo
SRStefano Rosato
Stefano Rosato
Fausto BiancariFausto Biancari
Fausto Biancari
MFMARCO FORTI
MARCO FORTI
FSFulvia Seccareccia
Fulvia Seccareccia
Our goal was to evaluate the impact of gender on the 10-year outcome of patients after isolated coronary artery bypass grafting (CABG) included in the Italian nationwide PRedictIng long-term Outcomes afteR Isolated coronary arTery bypass surgery (PRIORITY) study. The PRIORITY project was designed to evaluate the long-term outcomes of patients who underwent CABG and were included in 2 prospective multicentre cohort studies. The primary end point of this analysis was major adverse cardiac and cerebrovascular events. Baseline differences between the study groups were balanced with propensity score matching and inverse probability of treatment. Time to events was analysed using Cox regression and competing risk analysis. The study population comprised 10 989 patients who underwent isolated CABG (women 19.6%). Propensity score matching produced 1898 well-balanced pairs. The hazard of major adverse cardiac and cerebrovascular event was higher in women compared to men [adjusted hazard ratio (HR) 1.13, 95% confidence interval (CI) 1.03–1.23; P = 0.009]. The incidence of major adverse cardiac and cerebrovascular event in women was significantly higher at 1 year (HR 1.31, 95% CI 1.11–1.55; P < 0.001) and after 1 year (HR 1.11, 95% CI 1.00–1.24; P = 0.05). Mortality at 10 years in the matched groups was comparable (HR 1.04, 95% CI 0.93–1.16; P = 0.531). Women have significantly a higher 10-year risk of myocardial infarction (adjusted HR 1.40, 95% CI 1.17–1.68; P = 0.002) and percutaneous coronary intervention (adjusted HR 1.32, 95% CI 1.10–1.59; P = 0.003). The present study documented an excess of non-fatal cardiac events after CABG among women despite comparable 10-year survival with men. These findings suggest that studies investigating measures of tertiary prevention are needed to decrease the risk of adverse cardiovascular events among women.